Primary Total: $52,502,661
Total: $42,538,086
Primary Total: $39,077,134
Total: $193,984
Primary Total: $193,984
A Multicenter, Couble-Blind, Randomized, Placebo-Controlled Study to Assess the Efficicacy and Tolerability of Tizanidin e Tablets in Patients Suffering From Spasticity Resulting Fr om Spinal Cord Injury, (426968), Bio Pharm Clinical Services Inc, $30,964 (adjustment).
*Free Radicals, Apoptosis and Treatment of Decubitus Ulcers, (427704), Child Health and Human Development, $163,018 (adjustment).
*Disability Supplement to Promote Recruitment of Individuals with Disabilities; Free Radicals, Apoptosis & Treatment of Decubitus Ulcers, (432953), Child Health and Human Development, $15,930 (adjustment).
*A Multicenter, Evaluator-Blind, Three-Arm Study of the Study of the Safety and Efficacy of Bucladesine Sodium Ointment in the Treatment of Stage III Pressure Ulcers in Patients with Spinal Cord Injuries, (460043), Daiichi Pharmaceutical Corp, $2.
For questions regarding listings, contact Ms. Deborah Davis, director of the Office of Sponsored Projects Administration, 214 Kinkead Hall, 0057, phone 257-8311. (ddavis@pop.uky.edu )
Last Updated: 6/30/03